News
4h
Live Science on MSNOzempic-style drugs treat type 1 diabetes, not only type 2, study findsA clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...
Type 2 diabetes can be managed and sometimes reversed through lifestyle changes; medication may be necessary for more severe cases. Typically, the hormone insulin helps move glucose from your ...
In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...
The early results from the ReCET study were shared at Digestive Disease Week in 2023 and have sparked excitement in the ...
“ATR-258, a synthetic small molecule, has favourable pharmacokinetics and in Phase 1 clinical trials has been administered just once a day as a capsule, making it a straightforward, patient-friendly ...
Dapagliflozin plus methylcobalamin improved nerve function and glucose control in diabetic neuropathy.
Discover how a 5-day fasting-mimicking diet revolutionizes type 2 diabetes management, reducing medications and improving ...
10d
MedPage Today on MSNOnce-Weekly Basal Insulin Non-Inferior to Several Daily Options in Type 2 DiabetesCHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...
No longer just a condition of middle age, type 2 diabetes is increasingly affecting children, teenagers and young adults in ...
A drug commonly used to treat type 2 diabetes may reduce excess fluid in the brains of patients with hydrocephalus, which ...
Participants were designated as having type 2 diabetes if they had a hemoglobin A1C of 6.5% or greater, were taking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results